| Schedule of Segment Reporting Information, About the Company’s Significant Expenses |
The following table provides information about the Company’s significant expenses provided to the CEO and includes the reconciliation to income (loss) before income taxes: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Three Months Ended September 30, | | Nine Months Ended September 30, | | | 2025 | | 2024 | | 2025 | | 2024 | | | | | | | | | | | Net product revenue | | $ | 77,467 | | | $ | 50,025 | | | $ | 198,107 | | | $ | 118,707 | | | Cost of products sold | | (4,116) | | | 6,155 | | | 7,827 | | | 10,465 | | | Gross profit | | 81,583 | | | 43,870 | | | 190,280 | | | 108,242 | | | Operating expenses: | | | | | | | | | | Research and development expenses | | 27,010 | | | 3,803 | | | 35,619 | | | 10,922 | | | General and administrative expenses | | 19,853 | | | 18,328 | | | 54,941 | | | 68,577 | | | Selling and marketing expenses | | 27,701 | | | 17,344 | | | 75,827 | | | 53,733 | | | Other segment items* | | 5,082 | | | 4,722 | | | 16,073 | | | 14,112 | | | Total operating expenses | | 79,646 | | | 44,197 | | | 182,460 | | | 147,344 | | | Operating income (loss) | | 1,937 | | | (327) | | | 7,820 | | | (39,102) | | | Investment and other income, net | | 532 | | | 610 | | | 895 | | | 3,114 | | | Interest expense | | (2,415) | | | (2,820) | | | (7,008) | | | (8,128) | | | | | | | | | | | | Income (loss) before income taxes | | $ | 54 | | | $ | (2,537) | | | $ | 1,707 | | | $ | (44,116) | |
*For the three and nine months ended September 30, 2025 and 2024, the other segment items category includes quality and regulatory expenses and medical affairs expenses.
|